Halozyme Therapeutics shares owned by Myriad Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Myriad Asset Management
from 13F filings
Historical chart of Myriad Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Myriad Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Myriad Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-03-31 | $3.1M | 77k | 39.88 |
| 2021-12-31 | $3.1M | 77k | 40.21 |
| 2021-09-30 | $2.5M | 61k | 40.68 |